港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

康方生物

87.800

+1.5501.80%

成交量：284.06萬

成交額：2.50億

市值：788.44億

市盈率：-135.38

高：88.950

開：86.500

低：85.850

收：86.250

資料載入中...

總覽公司新聞公告

【熱門行業】全球競逐加速中國創新藥行業進入新週期

港股收盤(04.24) | 恒指收跌0.74% 科網股普遍調整醫藥股逆勢走強

【券商聚焦】中信里昂維持康方生物(09926)“優於大市”評級指其治療肺癌藥物取得積極結果或促進銷售增長

交銀國際：升康方生物目標價至115港元續列為行業重點推薦個股

每日醫刻｜貴州省衞健委副主任被查；康方生物官宣其PD-1“頭對頭”擊敗百濟神州替雷利珠單抗

港股午評|恒生指數跌1.21% 恒生生物科技指數逆市走強

交銀國際：升康方生物(09926)目標價至115港元續列為行業重點推薦個股

康方生物依沃西再次頭對頭戰勝PD1單抗，有望成為下一代免疫治療的基石藥物

康方生物高開逾6% 依沃西再次頭對頭戰勝PD1單抗

康方生物盤中異動早盤急速拉昇6.35%報98.800港元

港股概念追蹤|康方生物新藥臨牀再獲成功中國創新藥在全球肺癌診療上挑起大梁（附概念股）

港股異動 | 康方生物(09926)高開逾6% 依沃西再次頭對頭戰勝PD1單抗公司首款自免產品獲批

智通财经网

【特約大V】鄧聲興：市場憧憬貿易協議在望，港股A股回升

康方生物(9926.HK)：AK112-306PFS強陽性看好全球一線臨牀加速

康方生物(9926.HK)：SQNSCLC頭對頭戰勝PD-1聯合化療再證AK112潛力

中信建投证券

康方生物再次贏下頭對頭臨牀研究中國創新藥在全球肺癌診療上挑起大梁

每日经济新闻

南向資金今日大幅淨賣出181.07億元。港股通（滬）方面，盈富基金、恒生中國企業分別獲淨賣出40.73億港元、40.25

里昂：升康方生物目標價至112.6港元維持“跑贏大市”評級

又一次“頭對頭”勝出！康方生物雙抗藥物療效“擊敗”百濟神州PD-1

里昂：升康方生物(09926)目標價至112.6港元維持“跑贏大市”評級

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/09926/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09926","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","market":"HK","secType":"STK","nameCN":"康方生物","latestPrice":87.8,"timestamp":1746173305036,"preClose":86.25,"halted":0,"volume":2840564,"delay":0,"floatShares":898000000,"shares":898000000,"eps":-0.6485501865055685,"marketStatus":"已收盤","change":1.55,"latestTime":"05-02 16:08:25","open":86.5,"high":88.95,"low":85.85,"amount":249929431,"amplitude":0.035942,"askPrice":87.8,"askSize":21000,"bidPrice":87.75,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.6485501865055685,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":5,"adr":0,"listingDate":1587657600000,"exchange":"SEHK","adjPreClose":86.25,"openAndCloseTimeList":[[1746149400000,1746158400000],[1746162000000,1746172800000]],"volumeRatio":0.113016,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","floatShares":898000000,"roa":"-4.16%","roe":"-8.89%","lyrEps":-0.64855,"volumeRatio":0.113016,"shares":898000000,"dividePrice":0,"high":88.95,"amplitude":0.035942,"preClose":86.25,"low":85.85,"week52Low":26.45,"pbRate":"10.79","psRate":"34.60","week52High":105.5,"institutionHeld":0,"latestPrice":87.8,"committee":-0.909091,"eps":-0.6485501865055685,"divideRate":0,"volume":2840564,"delay":0,"ttmEps":-0.6485501865055685,"open":86.5,"prevYearClose":60.7,"prevWeekClose":98.9,"prevMonthClose":86.25,"prevQuarterClose":76.2,"fiveDayClose":100,"twentyDayClose":76.2,"sixtyDayClose":59.65},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09926\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529349605","title":"【熱門行業】全球競逐加速 中國創新藥行業進入新週期","url":"https://stock-news.laohu8.com/highlight/detail?id=2529349605","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529349605?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 18:06","pubTimestamp":1745489202,"startTime":"0","endTime":"0","summary":"这一举措直接惠及映恩生物等创新药企。特朗普政府宣布对药品加征关税后，市场担忧依赖美国市场的企业将承压。美国作为全球最大采浆国，其人血白蛋白长期占据中国市场主导地位；高端医疗器械领域亦以进口产品为主。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/NzE2MmQxNjEyNzIzMzUyNjY5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NzE2MmQxNjEyNzIzMzUyNjY5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1957660","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","LU0417516571.SGD","LU0348784397.USD","02696","LU2488822045.USD","BK1574","159992","06978","LU1720050803.USD","IE00B543WZ88.USD","09926","LU1794554557.SGD","09606","LU0348783233.USD","IE00B5MMRT66.SGD","BK1161"],"gpt_icon":1},{"id":"2529070678","title":"港股收盤(04.24) | 恒指收跌0.74% 科網股普遍調整 醫藥股逆勢走強","url":"https://stock-news.laohu8.com/highlight/detail?id=2529070678","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529070678?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 16:43","pubTimestamp":1745484187,"startTime":"0","endTime":"0","summary":"截止收盘，恒生指数跌0.74%或162.86点，报21909.76点，全日成交额2047.6亿港元；恒生国企指数跌0.73%，报8056.85点；恒生科技指数跌1.46%，报4975.89点。截至收盘，涨1.69%，报36.05港元，成交额4.43亿港元，贡献恒指0.67点。凯莱英公布2025年第一季度业绩，营业收入约15.41亿元，同比增长10.1%；归属于上市公司股东的净利润约3.27亿元，同比增长15.83%。截至收盘，跌3.95%，报2","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283963.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HHImain","BK1555","BK1524","BK1161","BK1515","09939","HSTECH","513600","HSI","01918","01816","BK1574","LU0348784397.USD","LU1720050803.USD","LU1794554557.SGD","BK1240","LU0417516571.SGD","LU2328871848.SGD","BK1129","BK1125","09696","02833","BK1594","IE00B543WZ88.USD","09926","BK1583","159938","BK1505","BK4614","IE00BPRC5H50.USD","BK1521","03939","SG9999014674.SGD","LU1969619763.USD","YANG","BK1190","09995","MCHmain","IE00B5MMRT66.SGD","LU0348783233.USD","LU2488822045.USD","BK1592"],"gpt_icon":1},{"id":"2529641231","title":"【券商聚焦】中信里昂維持康方生物(09926)“優於大市”評級 指其治療肺癌藥物取得積極結果或促進銷售增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2529641231","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529641231?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 13:45","pubTimestamp":1745473538,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信里昂发研指，康方生物(09926)较早前刊发公告指，旗下治疗肺癌药物三期临床试验取得显着阳性结果，为双特异性抗体新药依达方，联合化疗对比替雷利珠单抗联合化疗一线治疗晚期鳞状非小细胞肺癌的III期头对头临床试验，经独立数据监察委员会评估，期中分析显示强阳性结果，达到无进展生存期的主要研究终点。研究详细数据将在今年相关国际术会议上公布。该行认为公司治疗肺癌药物临床试验时间表稍早于该行预期，应对公司销售增长有正面作用。该行维持“优于大市”评级，并上目标价18%，由95.3港元调整至112.6港元，","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1957638","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"gpt_icon":0},{"id":"2529664823","title":"交銀國際：升康方生物目標價至115港元 續列為行業重點推薦個股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529664823","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529664823?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 12:23","pubTimestamp":1745468580,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　交银国际发布研报称，依沃西第二项头对头III期研究成功，首款自免产品获批，将康方生物（09926）2025至2027财年收入预测上调0%至6%，同时上调“依沃西”中国内地和海外经PoS调整销售高峰，分别至61亿元人民币及57亿美元。同时上调H股目标价至115港元，给予“买入”评级，继续列为行业重点推荐。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：史丽君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2025-04-24/doc-ineufssw2379982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09926"],"gpt_icon":0},{"id":"2529860620","title":"每日醫刻｜貴州省衞健委副主任被查；康方生物官宣其PD-1“頭對頭”擊敗百濟神州替雷利珠單抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2529860620","media":"财健道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529860620?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 12:06","pubTimestamp":1745467592,"startTime":"0","endTime":"0","summary":"5百济神州已在日本组建研发注册销售团队日前，百济神州的泽布替尼和替雷利珠单抗分别获得PMDA批准。7康方生物宣布其PD-1/VEGF抗体依沃西单抗无进展生存期数据头对头击败百济神州4月23日，康方生物宣布其PD-1/VEGF抗体依沃西单抗无进展生存期数据头对头击败百济神州PD-1药物替雷利珠单抗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424161741a4650705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424161741a4650705&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","LU1969619763.USD","BK1500","06160","LU0417516571.SGD","LU0348784397.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","BK1161","IE00B5MMRT66.SGD","LU0588546209.SGD","BK1588","LU1794554557.SGD","LU2328871848.SGD","BK1574","LU2488822045.USD","LU1720050803.USD","LU0348783233.USD","BK1583","LU0307460666.USD"],"gpt_icon":0},{"id":"2529610986","title":"港股午評|恒生指數跌1.21%       恒生生物科技指數逆市走強","url":"https://stock-news.laohu8.com/highlight/detail?id=2529610986","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529610986?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 12:00","pubTimestamp":1745467206,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数跌1.21%，跌267点，报21805点；恒生科技指数跌2.04%。港股早盘成交1222亿港元。恒生生物科技指数逆市上涨，机构看好创新药出海及部分生物药公司国产替代。一脉阳光涨超6%，CT胸部病变标注数据正式通过上海数据交易所合规审核并成功上架。荣昌生物涨超8%，维迪西妥单抗一线治疗胃癌结果入选2025 ASCO口头报告。上美股份涨超6%创新高，拟成立合资公司打造新品牌，主力品牌韩束增长势能强劲。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159892","LU2328871848.SGD","LU0348784397.USD","IE00BPRC5H50.USD","HHImain","HSTECH","IE00B5MMRT66.SGD","02833","09926","LU1969619763.USD","BK4614","LU0348783233.USD","LU1720050803.USD","YANG","LU2488822045.USD","MCHmain","BK1161","LU1794554557.SGD","HSI","BK1574","01801","513600","BK1583","IE00B543WZ88.USD","BK1589","LU0417516571.SGD"],"gpt_icon":1},{"id":"2529614767","title":"交銀國際：升康方生物(09926)目標價至115港元 續列為行業重點推薦個股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529614767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529614767?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 11:14","pubTimestamp":1745464489,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，依沃西第二项头对头III期研究成功，首款自免产品获批，将康方生物(09926)2025至2027财年收入预测上调0%至6%，同时上调“依沃西”中国内地和海外经PoS调整销售高峰，分别至61亿元人民币及57亿美元。同时上调H股目标价至115港元，给予“买入”评级，继续列为行业重点推荐。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09926"],"gpt_icon":0},{"id":"2529705619","title":"康方生物依沃西再次頭對頭戰勝PD1單抗，有望成為下一代免疫治療的基石藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2529705619","media":"国信证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529705619?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 10:15","pubTimestamp":1745460934,"startTime":"0","endTime":"0","summary":"事项：公司公告：依沃西联合化疗对比替雷利珠单抗联合化疗一线治疗晚期鳞状非小细胞肺癌的3期头对头临床试验期中分析显示强阳性结果：达到PFS的主要临床终点，具有统计学显著意义和重大临床获益。投资建议：康方生物的依沃西再次在3期临床中头对头战胜PD1单抗，不断验证其FIC和BIC的潜质。依沃西在今年还将迎来重要数据读出和全球注册性临床的持续推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424103046a6c5f145&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424103046a6c5f145&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","09926","BK1574","BK1161","LU0417516571.SGD","LU0348784397.USD","LU1720050803.USD","LU1794554557.SGD","IE00B5MMRT66.SGD","LU0348783233.USD","LU2488822045.USD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2529618395","title":"康方生物高開逾6% 依沃西再次頭對頭戰勝PD1單抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2529618395","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529618395?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 09:41","pubTimestamp":1745458860,"startTime":"0","endTime":"0","summary":"　　康方生物高开逾6%，截至发稿，股价上涨6.24%，现报98.70港元，成交额6.64亿港元。　　交银国际认为，依沃西第二项头对头III期成功，进一步验证了其在肺癌领域相较PD-1单靶药物的竞争优势，同时该适应症的后续报产、获批也将增厚短期业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-24/doc-ineufnky2442785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B5MMRT66.SGD","09926","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU1720050803.USD","LU0417516571.SGD","LU0348784397.USD","LU1794554557.SGD","BK1161","LU0348783233.USD","BK1574","LU2488822045.USD"],"gpt_icon":0},{"id":"2529613013","title":"康方生物盤中異動 早盤急速拉昇6.35%報98.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529613013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529613013?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 09:30","pubTimestamp":1745458208,"startTime":"0","endTime":"0","summary":"2025年04月24日早盘09时30分，康方生物股票出现异动，股价急速上涨6.35%。资金方面，该股资金流入721.305万港元，流出759.185万港元。康方生物股票所在的生物技术行业中，整体跌幅为0.35%。该信息摘要如下：里昂发布研报称，将康方生物目标价由95.3港元上调至112.6港元，维持“跑赢大市”评级。另外，里昂将康方生物2025至2027财年的销售预测，分别上调1%、2.3%及3.8%；净利润预测分别上调5.9%、4.8%及7.3%，以反映积极的临床进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042409300894e043c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042409300894e043c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","LU1794554557.SGD","IE00B5MMRT66.SGD","LU0348784397.USD","LU0417516571.SGD","IE00BPRC5H50.USD","BK1161","LU1720050803.USD","09926","IE00B543WZ88.USD","BK1574","LU0348783233.USD"],"gpt_icon":0},{"id":"2529690601","title":"港股概念追蹤|康方生物新藥臨牀再獲成功    中國創新藥在全球肺癌診療上挑起大梁（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2529690601","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529690601?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 09:25","pubTimestamp":1745457906,"startTime":"0","endTime":"0","summary":"而在全球市场，中国创新药正在肺癌诊疗上挑起大梁。康方生物董事长夏瑜表示，中国创新能力越来越强，新药开发的效率更高、成本更低，部分技术领域达到国际先进水平，甚至领跑全球。国产创新药的研发进度和临床数据越来越在全球范围内占到优势，创新药BD出海受关税影响较小，有望继续通过授权出海的形式实现全球的商业化价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","01801","159992","IE00BPRC5H50.USD","LU1794554557.SGD","HSTECH","BK1574","LU2488822045.USD","IE00B5MMRT66.SGD","BK1589","IE00B543WZ88.USD","LU0348783233.USD","06978","YANG","09926","BK1161","BK1583","LU0417516571.SGD","LU1720050803.USD","LU1969619763.USD","LU0348784397.USD","BK4614"],"gpt_icon":1},{"id":"2529697222","title":"港股異動 | 康方生物(09926)高開逾6% 依沃西再次頭對頭戰勝PD1單抗 公司首款自免產品獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2529697222","media":"智通财经网","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529697222?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 09:24","pubTimestamp":1745457840,"startTime":"0","endTime":"0","summary":"康方生物高开逾6%，截至发稿，涨6.03%，报98.5港元，成交额3555.85万港元。消息面上，康方生物宣布，依沃西联合化疗对比替雷利珠单抗联合化疗一线治疗晚期鳞状非小细胞肺癌的3期头对头临床试验期中分析显示强阳性结果：达到PFS的主要临床终点，具有统计学显著意义和重大临床获益。交银国际认为，依沃西第二项头对头III期成功，进一步验证了其在肺癌领域相较PD-1单靶药物的竞争优势，同时该适应症的后续报产、获批也将增厚短期业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-24/doc-ineufnmc3711797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0348784397.USD","IE00BPRC5H50.USD","LU1720050803.USD","IE00B543WZ88.USD","09926","BK1574","LU0348783233.USD","LU2488822045.USD","BK1161","LU1794554557.SGD","IE00B5MMRT66.SGD","LU0417516571.SGD"],"gpt_icon":0},{"id":"2529942536","title":"【特約大V】鄧聲興：市場憧憬貿易協議在望，港股A股回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2529942536","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529942536?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 08:48","pubTimestamp":1745455709,"startTime":"0","endTime":"0","summary":"市场憧憬贸易协议在望，港股A股回升。2024年公司扣除分销成本后的销售收入达20.0亿元，同比增长25%，主要受核心产品卡度尼利和依沃西强劲销售驱动。随着卡度尼利和依沃西于2024年底成功纳入医保，预计将迎来新一轮销售放量。凭藉卓越的创新研发能力和不断扩大的商业化版图，康方生物正逐步实现从研发型企业向研发商业一体化生物制药公司的战略转型，未来发展前景广阔。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MWY0ODA2ODZlZDJkOGFjZmU0MjQxNzIxNjM4MTkyODI0OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MWY0ODA2ODZlZDJkOGFjZmU0MjQxNzIxNjM4MTkyODI0OA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1957603","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399300","LU0463099449.HKD","HK0000320264.USD","LU0181495838.USD","LU0345780281.USD","LU0417516571.SGD","LU0572944931.SGD","LU2097828805.USD","LU0096374516.USD","LU2488822045.USD","LU1794554557.SGD","IE00BPRC5H50.USD","LU0345780521.USD","LU2097828631.EUR","YANG","BK1505","LU0140636845.USD","HSTECH","HK0000306701.USD","LU0370786039.SGD","159982","LU2097828557.USD","LU1303224171.USD","LU1719994722.HKD","HK0000320223.HKD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU2039709279.SGD","LU0244354667.USD","LU0348783233.USD","LU0326950275.SGD","LU0327786744.USD","BK1592","LU1048596156.SGD","LU2399975544.HKD","09926","LU1831875114.USD","BK1161","BK1574","LU0348784397.USD","BK1544","BK1198","LU1961090484.USD","LU2097828474.EUR","LU2097828714.EUR","LU0821914370.USD","LU1251922891.USD"],"gpt_icon":1},{"id":"2529614371","title":"康方生物(9926.HK)：AK112-306PFS強陽性 看好全球一線臨牀加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2529614371","media":"华泰证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529614371?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 00:00","pubTimestamp":1745424000,"startTime":"0","endTime":"0","summary":"4 月23 日公司公告宣布，AK112-306 中期分析强阳性结果，成为依沃西单抗在NSCLC 领域斩获的第2 个头对头阳性结果，标志着本品向肺癌全适应症重磅药迈进：1）将一线人群拓展至PD-L1 阴性患者；2）强化了在联用化疗、鳞癌患者中对传统PD-1 单抗的优效证据，海外一线III 期研究成功前景或更加明朗；3）参考既往Summit 在国内注册临床达终点后加速对应海外研究速度，HARMONi-3 或加速推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424110121a6c5f8ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424110121a6c5f8ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU1720050803.USD","LU0348783233.USD","LU1794554557.SGD","IE00BPRC5H50.USD","LU0417516571.SGD","BK1161","09926","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2488822045.USD","LU0348784397.USD"],"gpt_icon":1},{"id":"2529092982","title":"康方生物(9926.HK)：SQNSCLC頭對頭戰勝PD-1聯合化療 再證AK112潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=2529092982","media":"中信建投证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529092982?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 00:00","pubTimestamp":1745424000,"startTime":"0","endTime":"0","summary":"简评一、 sqNSCLC 头对头战胜PD-1 联合化疗，再证AK112 潜力2025 年4 月23 日，康方生物宣布依沃西联合化疗一线治疗sq-NSCLC获显著阳性结果，HARMONi-6 成为首个针对sqNSCLC 头对头PD-1 联合化疗并取得阳性结果的III 期临床。与治疗相关的严重不良反应发生率以及三级及以上出血事件发生率与对照组相似。HARMONi-6 研究是依沃西在非小细胞肺癌领域取得的第3 个显著阳性结果的III 期临床研究，填补了抗血管生成机制药物在sq-NSCLC 中不可用的巨大临床空白。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424203239a4656043&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424203239a4656043&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","BK1574","IE00BPRC5H50.USD","LU0348783233.USD","LU1720050803.USD","IE00B543WZ88.USD","LU1794554557.SGD","IE00B5MMRT66.SGD","LU2488822045.USD","BK1161","LU0417516571.SGD","LU0348784397.USD"],"gpt_icon":1},{"id":"2529506632","title":"康方生物再次贏下頭對頭臨牀研究 中國創新藥在全球肺癌診療上挑起大梁","url":"https://stock-news.laohu8.com/highlight/detail?id=2529506632","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529506632?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 23:51","pubTimestamp":1745423495,"startTime":"0","endTime":"0","summary":"康方生物双抗药物依沃西单抗（PD-1/VEGF双抗）又一次在头对头试验中战胜了PD-1，这次挑战的对象是百济神州的替雷利珠单抗联合疗法。消息显示，依沃西单抗联合化疗对比替雷利珠单抗联合化疗一线治疗晚期鳞状非小细胞肺癌（sq-NSCLC）的注册性三期临床研究（AK112-306/HARMONi-6），头对头试验显示强阳性结果，研究结果具有统计学显著获益和重大临床获益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504233386244345.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504233386244345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0348784397.USD","IE00BPRC5H50.USD","LU1720050803.USD","IE00B543WZ88.USD","09926","BK1574","LU0348783233.USD","LU2488822045.USD","BK1161","LU1794554557.SGD","06978","IE00B5MMRT66.SGD","LU0417516571.SGD"],"gpt_icon":1},{"id":"2529573372","title":"南向資金今日大幅淨賣出181.07億元。港股通（滬）方面，盈富基金、恒生中國企業分別獲淨賣出40.73億港元、40.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2529573372","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529573372?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 17:31","pubTimestamp":1745400682,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["09926","LU0873338254.USD","YANG","LU0821914370.USD","BK1142","BK1591","LU0588545904.SGD","MPNGY","LU0043850808.USD","LU0359202008.SGD","LU1770036033.HKD","03690","LU1328277881.USD","LU0051755006.USD","IE00B5MMRT66.SGD","LU0173614495.USD","LU0611395673.USD","HSCEI","LU0348814723.USD","LU0463099449.HKD","LU1868838027.USD","BK1604","07226","LU0348825331.USD","LU0054450605.USD","LU1323998911.USD","02800","LU2097828474.EUR","HMTD.SI","BK1521","LU0348827113.USD","HSTECH","LU0359201612.USD","SG9999002463.SGD","LU2045819591.USD","LU0052750758.USD","02828","LU0499858602.USD","LU1675838814.USD","LU0348805143.USD","LU0345776255.USD","LU0072913022.USD","SG9999002562.SGD","LU0132412106.USD","LU0348788117.USD","LU0128522157.USD","LU0054237671.USD","LU0431992006.USD","LU0348783233.USD","LU0572944931.SGD"],"gpt_icon":0},{"id":"2529524507","title":"里昂：升康方生物目標價至112.6港元 維持“跑贏大市”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2529524507","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529524507?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 16:44","pubTimestamp":1745397840,"startTime":"0","endTime":"0","summary":"　　里昂发布研报称，将康方生物目标价由95.3港元上调至112.6港元，维持“跑赢大市”评级。另外，里昂将康方生物2025至2027财年的销售预测，分别上调1%、2.3%及3.8%；净利润预测分别上调5.9%、4.8%及7.3%，以反映积极的临床进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2025-04-23/doc-ineucyiq6702233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09926"],"gpt_icon":0},{"id":"2529952490","title":"又一次“頭對頭”勝出！康方生物雙抗藥物療效“擊敗”百濟神州PD-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2529952490","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529952490?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 16:41","pubTimestamp":1745397660,"startTime":"0","endTime":"0","summary":"早间，康方生物宣布，公司双抗药物依沃西单抗又一次在头对头试验中战胜了PD-1，这次挑战的对象是百济神州的替雷利珠单抗。4月23日，百济神州A股股价下跌1.42%。依沃西是康方生物自主研发的、全球首创PD-1/VEGF双特异性肿瘤免疫治疗药物。康方生物的依沃西选择对标的这两款PD-1单抗，都有一定的代表性。百济神州的替雷利珠单抗在中国，已取得领先的PD-1市场份额。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042316430794df5305&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042316430794df5305&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","LU1169590202.USD","ONC","688235","BK4023","LU1169589451.USD","09926","PD","BK4139"],"gpt_icon":0},{"id":"2529251285","title":"里昂：升康方生物(09926)目標價至112.6港元 維持“跑贏大市”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2529251285","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529251285?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 16:03","pubTimestamp":1745395396,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，里昂发布研报称，将康方生物目标价由95.3港元上调至112.6港元，维持“跑赢大市”评级。另外，里昂将康方生物2025至2027财年的销售预测，分别上调1%、2.3%及3.8%;净利润预测分别上调5.9%、4.8%及7.3%，以反映积极的临床进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283036.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09926"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09926\",params:#limit:5,,,undefined,":[{"date":"2025-03-30","symbol":"09926","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743298200000,"name":null,"time":"盤後","dateTimestamp":1743264000000,"actualEps":null},{"date":"2024-08-28","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null},{"date":"2024-03-18","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710725400000,"name":null,"time":"","dateTimestamp":1710691200000,"actualEps":null},{"date":"2023-08-29","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693272600000,"name":null,"time":"","dateTimestamp":1693238400000,"actualEps":null},{"market":"HK","date":"2023-04-27","symbol":"09926","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1682524800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09926\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09926\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.381,"buy":0.5714,"hold":0.0476,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":21,"updateTime":1745942400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09926\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09926","date":"2025-04-30","current":-140.988925,"percent":0.00742,"low":-163.883348,"twenty":-54.598286,"median":-23.982021,"eighty":13.592632,"high":20.221708,"avg":-26.175805,"sd":31.735279,"marketCap":77415858930},"quantilePoints":[{"date":"2020-05-08","current":-50.146246,"twenty":-54.430966,"median":-50.765107,"eighty":-50.046102,"marketCap":18429666200},{"date":"2020-05-15","current":-53.0553,"twenty":-54.153595,"median":-51.221035,"eighty":-50.046102,"marketCap":19421739329},{"date":"2020-05-22","current":-55.542078,"twenty":-56.818854,"median":-53.301351,"eighty":-50.146246,"marketCap":20266722282},{"date":"2020-05-29","current":-55.414226,"twenty":-57.202877,"median":-54.292281,"eighty":-50.518886,"marketCap":20188016564},{"date":"2020-06-05","current":-58.444689,"twenty":-58.967855,"median":-55.265323,"eighty":-50.732575,"marketCap":21447308046},{"date":"2020-06-12","current":-63.276404,"twenty":-59.542646,"median":-55.820181,"eighty":-50.765107,"marketCap":23218186692},{"date":"2020-06-19","current":-68.299799,"twenty":-60.537832,"median":-56.858534,"eighty":-51.676962,"marketCap":25107123914},{"date":"2020-06-26","current":-80.148198,"twenty":-63.334108,"median":-58.348972,"eighty":-52.779632,"marketCap":29435938382},{"date":"2020-07-03","current":-77.885169,"twenty":-66.643902,"median":-58.880358,"eighty":-53.202931,"marketCap":28648881206},{"date":"2020-07-10","current":-76.725563,"twenty":-70.305822,"median":-59.096072,"eighty":-53.649064,"marketCap":28491469771},{"date":"2020-07-17","current":-70.467076,"twenty":-73.692098,"median":-59.898011,"eighty":-54.044506,"marketCap":26209003960},{"date":"2020-07-24","current":-65.539086,"twenty":-72.620808,"median":-60.537717,"eighty":-54.320018,"marketCap":24280713879},{"date":"2020-07-31","current":-65.051015,"twenty":-71.63744,"median":-61.425183,"eighty":-54.696299,"marketCap":24241361020},{"date":"2020-08-07","current":-61.60528,"twenty":-71.199223,"median":-62.665648,"eighty":-55.108469,"marketCap":22982069539},{"date":"2020-08-14","current":-60.398898,"twenty":-70.692859,"median":-61.425183,"eighty":-55.354665,"marketCap":22588540951},{"date":"2020-08-21","current":-65.573062,"twenty":-70.162934,"median":-62.07047,"eighty":-55.490937,"marketCap":24634889608},{"date":"2020-08-28","current":-62.258841,"twenty":-69.624858,"median":-61.507641,"eighty":-55.875802,"marketCap":23572362421},{"date":"2020-09-04","current":-56.454938,"twenty":-69.299363,"median":-61.279481,"eighty":-56.312276,"marketCap":21447308046},{"date":"2020-09-11","current":-59.39532,"twenty":-69.034548,"median":-61.149297,"eighty":-56.381895,"marketCap":22588540951},{"date":"2020-09-18","current":-23.213534,"twenty":-68.783672,"median":-61.157004,"eighty":-56.381895,"marketCap":23847832432},{"date":"2020-09-25","current":-20.580693,"twenty":-68.608413,"median":-60.769842,"eighty":-55.354665,"marketCap":20975073740},{"date":"2020-09-30","current":-21.520592,"twenty":-68.49576,"median":-60.537717,"eighty":-54.51941,"marketCap":22037600928},{"date":"2020-10-09","current":-20.533232,"twenty":-68.261016,"median":-60.351714,"eighty":-53.10451,"marketCap":21329249469},{"date":"2020-10-16","current":-20.579561,"twenty":-67.599319,"median":-60.014098,"eighty":-50.561624,"marketCap":21368602328},{"date":"2020-10-23","current":-18.390768,"twenty":-65.566444,"median":-59.898011,"eighty":-36.752532,"marketCap":19125489376},{"date":"2020-10-30","current":-18.387929,"twenty":-65.53997,"median":-59.39532,"eighty":-22.333682,"marketCap":19125489376},{"date":"2020-11-06","current":-18.960772,"twenty":-65.539086,"median":-59.096072,"eighty":-21.714319,"marketCap":19951899411},{"date":"2020-11-13","current":-17.861227,"twenty":-65.495719,"median":-58.967855,"eighty":-21.20377,"marketCap":18810666506},{"date":"2020-11-20","current":-18.195519,"twenty":-65.439452,"median":-58.396831,"eighty":-20.827083,"marketCap":19282900812},{"date":"2020-11-27","current":-18.163703,"twenty":-65.051015,"median":-57.55027,"eighty":-20.533232,"marketCap":19204195094},{"date":"2020-12-04","current":-19.807773,"twenty":-64.515903,"median":-57.279422,"eighty":-20.022532,"marketCap":21093132316},{"date":"2020-12-11","current":-21.33702,"twenty":-64.452305,"median":-56.818854,"eighty":-20.137955,"marketCap":22667246668},{"date":"2020-12-18","current":-24.630996,"twenty":-64.186949,"median":-56.363634,"eighty":-20.421683,"marketCap":26209003960},{"date":"2020-12-24","current":-26.970119,"twenty":-63.818518,"median":-55.820181,"eighty":-20.432553,"marketCap":28727586924},{"date":"2020-12-31","current":-28.06698,"twenty":-63.629518,"median":-55.339775,"eighty":-20.494047,"marketCap":29908172688},{"date":"2021-01-08","current":-32.570823,"twenty":-63.597221,"median":-55.265323,"eighty":-20.51364,"marketCap":34984691473},{"date":"2021-01-15","current":-37.631162,"twenty":-63.40952,"median":-54.292281,"eighty":-20.570295,"marketCap":40403477353},{"date":"2021-01-22","current":-41.643907,"twenty":-63.295257,"median":-53.301351,"eighty":-20.580467,"marketCap":44693027527},{"date":"2021-01-29","current":-40.849406,"twenty":-63.217929,"median":-51.221035,"eighty":-20.705895,"marketCap":44202793221},{"date":"2021-02-05","current":-42.462881,"twenty":-63.20331,"median":-50.765107,"eighty":-20.737196,"marketCap":45673496138},{"date":"2021-02-11","current":-44.298428,"twenty":-63.199738,"median":-50.518886,"eighty":-20.809106,"marketCap":47716139078},{"date":"2021-02-19","current":-44.620302,"twenty":-63.148699,"median":-50.046102,"eighty":-20.827888,"marketCap":48083814807},{"date":"2021-02-26","current":-38.677591,"twenty":-62.923489,"median":-46.003712,"eighty":-21.003278,"marketCap":41588210258},{"date":"2021-03-05","current":-36.070462,"twenty":-62.63965,"median":-44.620302,"eighty":-21.129156,"marketCap":38687657283},{"date":"2021-03-12","current":-33.577269,"twenty":-62.438134,"median":-44.247826,"eighty":-21.158012,"marketCap":35950515744},{"date":"2021-03-19","current":-35.993074,"twenty":-62.327407,"median":-43.908841,"eighty":-21.185375,"marketCap":38524245848},{"date":"2021-03-26","current":-37.072786,"twenty":-62.202297,"median":-42.138278,"eighty":-21.221991,"marketCap":39504714459},{"date":"2021-04-01","current":-41.283195,"twenty":-62.015041,"median":-41.751169,"eighty":-21.266862,"marketCap":43875970351},{"date":"2021-04-09","current":-31.196593,"twenty":-61.70772,"median":-41.695813,"eighty":-21.319481,"marketCap":43590000339},{"date":"2021-04-16","current":-30.642009,"twenty":-61.527169,"median":-40.849406,"eighty":-21.393706,"marketCap":42977207457},{"date":"2021-04-23","current":-31.96013,"twenty":-61.441675,"median":-40.344151,"eighty":-21.433299,"marketCap":44938144680},{"date":"2021-04-30","current":-30.816187,"twenty":-61.312504,"median":-39.558199,"eighty":-21.441654,"marketCap":43508294622},{"date":"2021-05-07","current":-28.864106,"twenty":-61.27851,"median":-38.69692,"eighty":-21.489217,"marketCap":41016270235},{"date":"2021-05-14","current":-29.343194,"twenty":-61.208677,"median":-38.024901,"eighty":-21.636828,"marketCap":41669915976},{"date":"2021-05-21","current":-32.815059,"twenty":-61.158545,"median":-37.656345,"eighty":-21.839766,"marketCap":46613111890},{"date":"2021-05-28","current":-34.118192,"twenty":-61.102433,"median":-37.609185,"eighty":-22.049324,"marketCap":48941724842},{"date":"2021-06-04","current":-35.625611,"twenty":-60.979677,"median":-37.553441,"eighty":-22.116923,"marketCap":50861809206},{"date":"2021-06-10","current":-37.08623,"twenty":-60.769842,"median":-37.072786,"eighty":-22.258985,"marketCap":52986157863},{"date":"2021-06-18","current":-35.659842,"twenty":-60.584234,"median":-36.485136,"eighty":-22.270088,"marketCap":50494133476},{"date":"2021-06-25","current":-36.773665,"twenty":-60.537647,"median":-36.47778,"eighty":-22.279086,"marketCap":51923983534},{"date":"2021-06-30","current":-36.160141,"twenty":-60.48212,"median":-36.485136,"eighty":-22.301737,"marketCap":51188632076},{"date":"2021-07-09","current":-33.001535,"twenty":-60.380024,"median":-36.358401,"eighty":-22.333501,"marketCap":46572259032},{"date":"2021-07-16","current":-33.61015,"twenty":-60.247205,"median":-36.160141,"eighty":-22.684742,"marketCap":47430169066},{"date":"2021-07-23","current":-30.660269,"twenty":-60.081955,"median":-36.081197,"eighty":-23.212212,"marketCap":43263177469},{"date":"2021-07-30","current":-29.749657,"twenty":-60.025123,"median":-35.993074,"eighty":-23.780519,"marketCap":42119297422},{"date":"2021-08-06","current":-26.92917,"twenty":-59.948494,"median":-35.665203,"eighty":-24.743522,"marketCap":38034011542},{"date":"2021-08-13","current":-25.592675,"twenty":-59.918873,"median":-35.597545,"eighty":-24.965673,"marketCap":36195632896},{"date":"2021-08-20","current":-20.885732,"twenty":-59.826938,"median":-35.459665,"eighty":-24.434422,"marketCap":29454911194},{"date":"2021-08-27","current":-21.082492,"twenty":-59.613719,"median":-35.394103,"eighty":-23.176546,"marketCap":29863439782},{"date":"2021-09-03","current":-31.115126,"twenty":-59.45425,"median":-35.211108,"eighty":-23.023412,"marketCap":34806635697},{"date":"2021-09-10","current":-32.055246,"twenty":-59.359698,"median":-34.971061,"eighty":-23.122707,"marketCap":35950515744},{"date":"2021-09-17","current":-31.163903,"twenty":-59.210176,"median":-34.572405,"eighty":-23.198629,"marketCap":34847488556},{"date":"2021-09-24","current":-31.295563,"twenty":-59.102123,"median":-34.437371,"eighty":-23.212212,"marketCap":35010899991},{"date":"2021-09-30","current":-31.154784,"twenty":-59.047908,"median":-34.407249,"eighty":-23.447883,"marketCap":34970047132},{"date":"2021-10-08","current":-29.845898,"twenty":-58.976264,"median":-34.085183,"eighty":-24.385279,"marketCap":33499344216},{"date":"2021-10-15","current":-32.807984,"twenty":-58.969537,"median":-33.89682,"eighty":-24.581853,"marketCap":36849278637},{"date":"2021-10-22","current":-33.585285,"twenty":-58.897857,"median":-33.786096,"eighty":-24.856047,"marketCap":37993158684},{"date":"2021-10-29","current":-31.568779,"twenty":-58.531823,"median":-33.627637,"eighty":-25.019036,"marketCap":35623692873},{"date":"2021-11-05","current":-28.336247,"twenty":-58.387259,"median":-33.581277,"eighty":-25.13981,"marketCap":32028641299},{"date":"2021-11-12","current":-31.135474,"twenty":-58.165915,"median":-33.566565,"eighty":-25.305935,"marketCap":35337722862},{"date":"2021-11-19","current":-36.658551,"twenty":-57.747713,"median":-33.576384,"eighty":-25.505551,"marketCap":41547357399},{"date":"2021-11-26","current":-34.737009,"twenty":-57.465203,"median":-33.61015,"eighty":-25.671516,"marketCap":39382155883},{"date":"2021-12-03","current":-31.939354,"twenty":-57.376977,"median":-33.627637,"eighty":-26.141756,"marketCap":36277338614},{"date":"2021-12-10","current":-30.771813,"twenty":-57.264113,"median":-33.577269,"eighty":-26.43668,"marketCap":35010899991},{"date":"2021-12-17","current":-26.05017,"twenty":-56.996271,"median":-33.456271,"eighty":-26.43668,"marketCap":29618322630},{"date":"2021-12-24","current":-24.338156,"twenty":-56.834726,"median":-33.106388,"eighty":-25.505551,"marketCap":27698238266},{"date":"2021-12-31","current":-24.356969,"twenty":-56.799582,"median":-33.044261,"eighty":-25.17902,"marketCap":27779943984},{"date":"2022-01-07","current":-20.242995,"twenty":-23.086945,"median":-21.779811,"eighty":-19.899701,"marketCap":23000159504},{"date":"2022-01-14","current":-20.701287,"twenty":-22.600464,"median":-21.033383,"eighty":-20.391327,"marketCap":23572099527},{"date":"2022-01-21","current":-18.577865,"twenty":-21.986595,"median":-20.680988,"eighty":-19.350843,"marketCap":21202633717},{"date":"2022-01-28","current":-14.534275,"twenty":-21.562934,"median":-20.260299,"eighty":-18.52558,"marketCap":16545407814},{"date":"2022-02-04","current":-14.146452,"twenty":-21.41835,"median":-20.123216,"eighty":-17.613539,"marketCap":16096026367},{"date":"2022-02-11","current":-13.816944,"twenty":-21.209422,"median":-19.299968,"eighty":-14.985471,"marketCap":15752862353},{"date":"2022-02-18","current":-13.849256,"twenty":-20.857344,"median":-18.911796,"eighty":-14.543623,"marketCap":15867250357},{"date":"2022-02-25","current":-14.199347,"twenty":-20.701287,"median":-17.613539,"eighty":-14.146452,"marketCap":16308461232},{"date":"2022-03-04","current":-14.080132,"twenty":-20.680988,"median":-15.318994,"eighty":-14.146452,"marketCap":16177732084},{"date":"2022-03-11","current":-11.936356,"twenty":-20.490215,"median":-14.985471,"eighty":-13.996814,"marketCap":13693878269},{"date":"2022-03-18","current":-11.726724,"twenty":-20.277602,"median":-14.700549,"eighty":-13.379502,"marketCap":13399737686},{"date":"2022-03-25","current":-12.670051,"twenty":-20.242995,"median":-14.554967,"eighty":-13.072377,"marketCap":14478253158},{"date":"2022-04-01","current":-9.59311,"twenty":-20.003436,"median":-14.538949,"eighty":-12.331764,"marketCap":12697068515},{"date":"2022-04-08","current":-10.156641,"twenty":-19.508494,"median":-14.196743,"eighty":-11.833638,"marketCap":13448761116},{"date":"2022-04-14","current":-9.530673,"twenty":-19.333884,"median":-14.131899,"eighty":-11.51878,"marketCap":12599021653},{"date":"2022-04-22","current":-8.780037,"twenty":-19.299831,"median":-14.060726,"eighty":-10.573986,"marketCap":11389777033},{"date":"2022-04-29","current":-9.576611,"twenty":-19.278065,"median":-13.849256,"eighty":-10.115287,"marketCap":12223175352},{"date":"2022-05-06","current":-7.86231,"twenty":-19.112154,"median":-13.498553,"eighty":-9.579911,"marketCap":9951756403},{"date":"2022-05-13","current":-8.110711,"twenty":-18.577865,"median":-13.379502,"eighty":-9.437455,"marketCap":10082485551},{"date":"2022-05-20","current":-9.061494,"twenty":-18.447152,"median":-13.096379,"eighty":-8.947629,"marketCap":11422459320},{"date":"2022-05-27","current":-8.809867,"twenty":-17.613539,"median":-12.670051,"eighty":-8.780037,"marketCap":11095636450},{"date":"2022-06-02","current":-11.227787,"twenty":-16.802517,"median":-12.331764,"eighty":-8.803901,"marketCap":14216794862},{"date":"2022-06-10","current":-12.109337,"twenty":-15.675042,"median":-12.221978,"eighty":-8.825148,"marketCap":15229945760},{"date":"2022-06-17","current":-11.667379,"twenty":-15.244074,"median":-11.936356,"eighty":-8.923897,"marketCap":14658005737},{"date":"2022-06-24","current":-16.485913,"twenty":-15.494316,"median":-12.221978,"eighty":-9.038721,"marketCap":20794105129},{"date":"2022-06-30","current":-14.957001,"twenty":-15.895364,"median":-12.380422,"eighty":-9.079607,"marketCap":18833167906},{"date":"2022-07-08","current":-15.913959,"twenty":-16.531452,"median":-12.638751,"eighty":-9.104893,"marketCap":20058753670},{"date":"2022-07-15","current":-15.322331,"twenty":-16.45611,"median":-12.887919,"eighty":-9.149933,"marketCap":19134050754},{"date":"2022-07-22","current":-14.807486,"twenty":-16.221667,"median":-13.200862,"eighty":-9.216155,"marketCap":18503257872},{"date":"2022-07-29","current":-14.117198,"twenty":-15.979822,"median":-13.449665,"eighty":-9.360153,"marketCap":17662200696},{"date":"2022-08-05","current":-15.298986,"twenty":-15.838747,"median":-13.498553,"eighty":-9.442,"marketCap":19091997895},{"date":"2022-08-12","current":-15.143556,"twenty":-15.77936,"median":-13.923035,"eighty":-9.496416,"marketCap":18923786460},{"date":"2022-08-19","current":-14.616817,"twenty":-15.77936,"median":-14.080132,"eighty":-9.558236,"marketCap":18082729284},{"date":"2022-08-26","current":-14.756101,"twenty":-15.738632,"median":-14.060726,"eighty":-9.58651,"marketCap":21573116564},{"date":"2022-09-02","current":-14.751536,"twenty":-15.714766,"median":-14.080132,"eighty":-9.724865,"marketCap":21489010846},{"date":"2022-09-09","current":-14.98178,"twenty":-15.703366,"median":-14.105484,"eighty":-9.977712,"marketCap":21741327999},{"date":"2022-09-16","current":-13.542084,"twenty":-15.658514,"median":-14.086951,"eighty":-10.115287,"marketCap":19470473624},{"date":"2022-09-23","current":-12.107338,"twenty":-15.550768,"median":-14.041319,"eighty":-10.199224,"marketCap":17073460672},{"date":"2022-09-30","current":-12.91765,"twenty":-15.461818,"median":-13.978573,"eighty":-10.287783,"marketCap":18250940719},{"date":"2022-10-07","current":-16.281937,"twenty":-15.588998,"median":-14.018764,"eighty":-10.343921,"marketCap":23002913763},{"date":"2022-10-14","current":-15.674276,"twenty":-15.588998,"median":-14.040715,"eighty":-10.440625,"marketCap":21909539434},{"date":"2022-10-21","current":-18.781307,"twenty":-15.710601,"median":-14.070137,"eighty":-10.570074,"marketCap":26072772456},{"date":"2022-10-28","current":-18.085263,"twenty":-15.888888,"median":-14.117198,"eighty":-10.76408,"marketCap":25063503844},{"date":"2022-11-04","current":-18.001131,"twenty":-16.380537,"median":-14.170295,"eighty":-10.773453,"marketCap":25189662421},{"date":"2022-11-11","current":-17.246398,"twenty":-16.644748,"median":-14.199347,"eighty":-10.843556,"marketCap":24348605245},{"date":"2022-11-18","current":-21.310798,"twenty":-17.050284,"median":-14.308051,"eighty":-11.043704,"marketCap":29983688324},{"date":"2022-11-25","current":-18.980602,"twenty":-17.498612,"median":-14.382807,"eighty":-11.22006,"marketCap":26493301044},{"date":"2022-12-02","current":-19.013979,"twenty":-17.995008,"median":-14.534799,"eighty":-11.242055,"marketCap":26997935349},{"date":"2022-12-09","current":-24.062263,"twenty":-18.437795,"median":-14.543856,"eighty":-11.359054,"marketCap":34483344216},{"date":"2022-12-16","current":-24.530301,"twenty":-18.889555,"median":-14.574904,"eighty":-11.602588,"marketCap":35072084239},{"date":"2022-12-23","current":-25.228352,"twenty":-19.041941,"median":-14.612379,"eighty":-11.627361,"marketCap":36081352850},{"date":"2022-12-30","current":-24.983629,"twenty":-19.09779,"median":-14.616563,"eighty":-11.655751,"marketCap":36165458568},{"date":"2023-01-06","current":-26.109825,"twenty":-19.246994,"median":-14.727609,"eighty":-11.666513,"marketCap":38183995790},{"date":"2023-01-13","current":-27.482086,"twenty":-19.35432,"median":-14.788719,"eighty":-11.675194,"marketCap":40959484471},{"date":"2023-01-20","current":-27.207673,"twenty":-19.72973,"median":-14.927803,"eighty":-11.681264,"marketCap":40202533012},{"date":"2023-01-27","current":-29.02317,"twenty":-19.973183,"median":-14.953302,"eighty":-11.681837,"marketCap":42893915976},{"date":"2023-02-03","current":-27.684735,"twenty":-20.135985,"median":-14.979187,"eighty":-11.694899,"marketCap":41127695906},{"date":"2023-02-10","current":-25.345976,"twenty":-20.490215,"median":-14.987339,"eighty":-11.726724,"marketCap":37427044332},{"date":"2023-02-17","current":-24.322978,"twenty":-20.857344,"median":-15.034554,"eighty":-11.784491,"marketCap":35576718544},{"date":"2023-02-24","current":-24.100109,"twenty":-21.41835,"median":-15.060613,"eighty":-11.860367,"marketCap":34819767086},{"date":"2023-03-03","current":-25.36278,"twenty":-22.807081,"median":-15.131721,"eighty":-11.936356,"marketCap":36880357167},{"date":"2023-03-10","current":-22.900092,"twenty":-23.768741,"median":-23.203261,"eighty":-23.03994,"marketCap":33053547016},{"date":"2023-03-17","current":-29.09369,"twenty":-36.802165,"median":-25.36278,"eighty":-15.020812,"marketCap":38688630096},{"date":"2023-03-24","current":-25.324343,"twenty":-36.777216,"median":-25.389232,"eighty":-15.036479,"marketCap":34062815628},{"date":"2023-03-31","current":-25.456261,"twenty":-36.704597,"median":-25.488573,"eighty":-15.049117,"marketCap":33978709910},{"date":"2023-04-06","current":-27.774061,"twenty":-36.623868,"median":-25.540624,"eighty":-15.058257,"marketCap":37048568602},{"date":"2023-04-14","current":-29.730818,"twenty":-36.485136,"median":-25.637411,"eighty":-15.064541,"marketCap":39697898707},{"date":"2023-04-21","current":-26.784111,"twenty":-36.470425,"median":-25.724076,"eighty":-15.129637,"marketCap":35744929980},{"date":"2023-04-28","current":-27.207269,"twenty":-36.436465,"median":-26.010547,"eighty":-15.131721,"marketCap":36039299991},{"date":"2023-05-05","current":-28.335447,"twenty":-36.311562,"median":-26.064869,"eighty":-15.141189,"marketCap":37595255767},{"date":"2023-05-12","current":-27.159579,"twenty":-36.18971,"median":-26.086367,"eighty":-15.143863,"marketCap":35786982838},{"date":"2023-05-19","current":-24.342298,"twenty":-36.161524,"median":-26.085247,"eighty":-15.156,"marketCap":31623749817},{"date":"2023-05-25","current":-24.063272,"twenty":-36.158475,"median":-26.064869,"eighty":-15.180082,"marketCap":31203221229},{"date":"2023-06-02","current":-23.645458,"twenty":-36.149195,"median":-25.984476,"eighty":-15.257042,"marketCap":30488322630},{"date":"2023-06-09","current":-23.222359,"twenty":-36.112659,"median":-25.723039,"eighty":-15.312993,"marketCap":29899582606},{"date":"2023-06-16","current":-24.58122,"twenty":-36.07905,"median":-25.633881,"eighty":-15.343575,"marketCap":31497591241},{"date":"2023-06-23","current":-21.944137,"twenty":-36.043198,"median":-25.488573,"eighty":-15.365065,"marketCap":27965151102},{"date":"2023-06-30","current":-23.543047,"twenty":-35.998611,"median":-25.389232,"eighty":-15.403178,"marketCap":29731371171},{"date":"2023-07-07","current":-23.989446,"twenty":-35.969849,"median":-25.36278,"eighty":-15.455833,"marketCap":30236005477},{"date":"2023-07-14","current":-24.41425,"twenty":-35.912278,"median":-25.312393,"eighty":-15.498928,"marketCap":31203221229},{"date":"2023-07-21","current":-24.59436,"twenty":-35.843663,"median":-25.202538,"eighty":-15.562817,"marketCap":31287326947},{"date":"2023-07-28","current":-28.426335,"twenty":-35.766034,"median":-25.264398,"eighty":-15.623426,"marketCap":36123405709},{"date":"2023-08-04","current":-24.11733,"twenty":-35.704573,"median":-25.300444,"eighty":-15.66297,"marketCap":30698586924},{"date":"2023-08-11","current":-22.294,"twenty":-35.666275,"median":-25.201022,"eighty":-15.683018,"marketCap":28217468254},{"date":"2023-08-18","current":-21.752014,"twenty":-35.64615,"median":-25.173816,"eighty":-15.703366,"marketCap":27334358220},{"date":"2023-08-25","current":-22.10921,"twenty":-35.616771,"median":-25.07893,"eighty":-15.714766,"marketCap":27796939666},{"date":"2023-09-01","current":13.494719,"twenty":-35.601124,"median":-25.008455,"eighty":-15.66297,"marketCap":28974419713},{"date":"2023-09-08","current":13.695117,"twenty":-35.550756,"median":-24.944029,"eighty":-15.455833,"marketCap":29058525430},{"date":"2023-09-15","current":14.848421,"twenty":-35.47221,"median":-24.903626,"eighty":-15.308324,"marketCap":31749908394},{"date":"2023-09-22","current":14.814862,"twenty":-35.438003,"median":-24.827647,"eighty":-15.14371,"marketCap":31539644100},{"date":"2023-09-29","current":14.197918,"twenty":-35.396385,"median":-24.772153,"eighty":-15.059828,"marketCap":30278058336},{"date":"2023-10-06","current":13.889059,"twenty":-35.370319,"median":-24.700469,"eighty":-15.007069,"marketCap":29605212595},{"date":"2023-10-13","current":15.431226,"twenty":-35.30592,"median":-24.632761,"eighty":-14.979706,"marketCap":32843282722},{"date":"2023-10-20","current":14.94053,"twenty":-35.232247,"median":-24.59436,"eighty":-14.914724,"marketCap":31749908394},{"date":"2023-10-27","current":16.35255,"twenty":-35.175876,"median":-24.58122,"eighty":-14.756101,"marketCap":34735661368},{"date":"2023-11-03","current":17.592659,"twenty":-35.129074,"median":-24.511377,"eighty":-14.616308,"marketCap":37469097190},{"date":"2023-11-10","current":18.939266,"twenty":-34.971061,"median":-24.417444,"eighty":-14.569406,"marketCap":40328691589},{"date":"2023-11-17","current":18.319814,"twenty":-34.968612,"median":-24.399566,"eighty":-14.535322,"marketCap":39361475836},{"date":"2023-11-24","current":18.189638,"twenty":-34.895357,"median":-24.342298,"eighty":-14.371526,"marketCap":39403528695},{"date":"2023-12-01","current":18.752497,"twenty":-34.737009,"median":-24.330293,"eighty":-14.199347,"marketCap":40791273036},{"date":"2023-12-08","current":16.771041,"twenty":-34.685609,"median":-24.255162,"eighty":-14.117346,"marketCap":36333670003},{"date":"2023-12-15","current":17.832719,"twenty":-34.615488,"median":-24.15298,"eighty":-14.060142,"marketCap":38856841531},{"date":"2023-12-22","current":16.203086,"twenty":-34.602221,"median":-24.100109,"eighty":-13.960331,"marketCap":35282348533},{"date":"2023-12-29","current":17.826838,"twenty":-34.566441,"median":-24.075355,"eighty":-13.84838,"marketCap":39025052966},{"date":"2024-01-05","current":16.831364,"twenty":-34.502078,"median":-24.025855,"eighty":-13.7643,"marketCap":36585987156},{"date":"2024-01-12","current":17.634525,"twenty":-34.43816,"median":-23.91516,"eighty":-13.515965,"marketCap":38352207225},{"date":"2024-01-19","current":16.051677,"twenty":-34.428025,"median":-23.817977,"eighty":-13.388012,"marketCap":34861819945},{"date":"2024-01-26","current":16.269899,"twenty":-34.417805,"median":-23.667454,"eighty":-13.261099,"marketCap":35198242815},{"date":"2024-02-02","current":15.531605,"twenty":-34.408725,"median":-23.587311,"eighty":-13.092715,"marketCap":33558181322},{"date":"2024-02-09","current":15.823479,"twenty":-34.287198,"median":-23.509747,"eighty":-12.88456,"marketCap":34357185639},{"date":"2024-02-16","current":17.001239,"twenty":-34.118192,"median":-23.29296,"eighty":-12.670051,"marketCap":36922410026},{"date":"2024-02-23","current":17.733723,"twenty":-34.052175,"median":-23.261464,"eighty":-12.429079,"marketCap":38310154366},{"date":"2024-03-01","current":18.170113,"twenty":-33.918444,"median":-23.222586,"eighty":-12.109337,"marketCap":39277370119},{"date":"2024-03-08","current":18.375936,"twenty":-33.875196,"median":-23.212231,"eighty":-11.784491,"marketCap":39739951566},{"date":"2024-03-15","current":20.221708,"twenty":-33.786096,"median":-23.186995,"eighty":-11.680404,"marketCap":43692920293},{"date":"2024-03-22","current":17.596046,"twenty":-33.777607,"median":-23.165857,"eighty":-11.598761,"marketCap":38772735813},{"date":"2024-03-28","current":17.863111,"twenty":-33.671621,"median":-23.133172,"eighty":-11.174522,"marketCap":39235317260},{"date":"2024-04-05","current":17.790526,"twenty":-33.631134,"median":-23.073507,"eighty":-10.781195,"marketCap":39050158637},{"date":"2024-04-12","current":19.515107,"twenty":-33.600204,"median":-23.002422,"eighty":-10.363031,"marketCap":42859930212},{"date":"2024-04-19","current":17.322126,"twenty":-33.582079,"median":-22.887987,"eighty":-9.922708,"marketCap":38011130026},{"date":"2024-04-26","current":19.239838,"twenty":-33.576561,"median":-22.815578,"eighty":-9.479287,"marketCap":42167244471},{"date":"2024-05-03","current":19.371749,"twenty":-33.573712,"median":-22.807081,"eighty":-9.18811,"marketCap":42427001624},{"date":"2024-05-10","current":19.700553,"twenty":-33.522448,"median":-22.755385,"eighty":-8.970402,"marketCap":43249565941},{"date":"2024-05-17","current":19.23578,"twenty":-33.345978,"median":-22.735553,"eighty":-8.780037,"marketCap":42167244471},{"date":"2024-05-24","current":14.667701,"twenty":-33.217784,"median":-22.607363,"eighty":-8.675073,"marketCap":32080008370},{"date":"2024-05-31","current":17.401421,"twenty":-33.106388,"median":-22.460124,"eighty":-8.554056,"marketCap":38097715744},{"date":"2024-06-07","current":16.096502,"twenty":-33.061925,"median":-22.417733,"eighty":-8.291628,"marketCap":35197094204},{"date":"2024-06-14","current":15.794192,"twenty":-33.047794,"median":-22.339227,"eighty":-8.117822,"marketCap":34504408463},{"date":"2024-06-21","current":14.159201,"twenty":-33.01008,"median":-22.315076,"eighty":-7.860137,"marketCap":30867808324},{"date":"2024-06-28","current":14.999486,"twenty":-32.90826,"median":-22.280642,"eighty":13.494356,"marketCap":32686108394},{"date":"2024-07-05","current":15.459781,"twenty":-32.881624,"median":-22.258985,"eighty":13.627238,"marketCap":33681844146},{"date":"2024-07-12","current":15.952998,"twenty":-32.86657,"median":-22.065202,"eighty":13.703744,"marketCap":34807458475},{"date":"2024-07-19","current":15.972541,"twenty":-32.832239,"median":-21.944137,"eighty":13.863497,"marketCap":34850751334},{"date":"2024-07-26","current":16.071567,"twenty":-32.814226,"median":-21.7966,"eighty":14.148348,"marketCap":35197094204},{"date":"2024-08-02","current":16.61499,"twenty":-32.811697,"median":-21.752014,"eighty":14.411832,"marketCap":36366001392},{"date":"2024-08-09","current":17.212345,"twenty":-32.808943,"median":-21.597174,"eighty":14.509977,"marketCap":37924544308},{"date":"2024-08-16","current":17.657405,"twenty":-32.804956,"median":-21.439655,"eighty":14.640353,"marketCap":38920280061},{"date":"2024-08-23","current":17.9547,"twenty":-32.79969,"median":-21.418042,"eighty":14.703604,"marketCap":39742844378},{"date":"2024-08-30","current":-52.624506,"twenty":-32.804956,"median":-21.417734,"eighty":14.818346,"marketCap":42513587341},{"date":"2024-09-06","current":-51.635037,"twenty":-32.832239,"median":-21.438942,"eighty":14.78042,"marketCap":41734315883},{"date":"2024-09-13","current":-66.216902,"twenty":-33.018625,"median":-21.520592,"eighty":14.703604,"marketCap":53380094900},{"date":"2024-09-20","current":-69.932725,"twenty":-33.173226,"median":-21.714319,"eighty":14.662246,"marketCap":56713645028},{"date":"2024-09-27","current":-71.531113,"twenty":-33.576561,"median":-21.771586,"eighty":14.652247,"marketCap":58358773662},{"date":"2024-10-04","current":-79.320454,"twenty":-33.638129,"median":-21.813706,"eighty":14.649255,"marketCap":64419773894},{"date":"2024-10-10","current":-69.213885,"twenty":-33.875196,"median":-21.986037,"eighty":14.648182,"marketCap":55847787852},{"date":"2024-10-18","current":-74.646599,"twenty":-34.399868,"median":-22.081407,"eighty":14.635134,"marketCap":59917316579},{"date":"2024-10-25","current":-77.719883,"twenty":-34.441314,"median":-22.265924,"eighty":14.560741,"marketCap":62380223732},{"date":"2024-11-01","current":-76.214752,"twenty":-34.685609,"median":-22.294,"eighty":14.556702,"marketCap":61213399403},{"date":"2024-11-08","current":-76.2814,"twenty":-34.971061,"median":-22.333531,"eighty":14.515997,"marketCap":60989010109},{"date":"2024-11-15","current":-78.00551,"twenty":-35.320815,"median":-22.40582,"eighty":14.505964,"marketCap":61707055850},{"date":"2024-11-22","current":-81.958791,"twenty":-35.480573,"median":-22.437728,"eighty":14.479729,"marketCap":64803628107},{"date":"2024-11-29","current":-83.036127,"twenty":-35.659842,"median":-22.470599,"eighty":14.463817,"marketCap":65611429565},{"date":"2024-12-06","current":-74.237179,"twenty":-35.878177,"median":-22.720101,"eighty":14.435399,"marketCap":58520727875},{"date":"2024-12-13","current":-72.615659,"twenty":-36.070462,"median":-22.745547,"eighty":14.396121,"marketCap":57129514252},{"date":"2024-12-20","current":-69.730236,"twenty":-36.160141,"median":-22.79318,"eighty":14.28027,"marketCap":54616354159},{"date":"2024-12-27","current":-68.121477,"twenty":-36.342788,"median":-22.81524,"eighty":14.230859,"marketCap":53314896254},{"date":"2025-01-03","current":-66.794572,"twenty":-36.589185,"median":-22.863096,"eighty":14.182431,"marketCap":52327583360},{"date":"2025-01-10","current":-64.575988,"twenty":-36.921451,"median":-22.916115,"eighty":14.151966,"marketCap":50397835432},{"date":"2025-01-17","current":-67.97132,"twenty":-37.388459,"median":-23.037405,"eighty":14.124517,"marketCap":53090506960},{"date":"2025-01-24","current":-71.487894,"twenty":-37.630978,"median":-23.112092,"eighty":14.06824,"marketCap":56187079217},{"date":"2025-01-28","current":-69.159217,"twenty":-37.749998,"median":-23.133265,"eighty":14.036856,"marketCap":54616354159},{"date":"2025-02-07","current":-74.204707,"twenty":-38.720974,"median":-23.179575,"eighty":13.91548,"marketCap":58296338581},{"date":"2025-02-14","current":-68.942526,"twenty":-39.742666,"median":-23.199597,"eighty":13.854976,"marketCap":54032941995},{"date":"2025-02-21","current":-78.532535,"twenty":-40.936164,"median":-23.213534,"eighty":13.833941,"marketCap":61886567285},{"date":"2025-02-28","current":-83.363188,"twenty":-41.78603,"median":-23.229233,"eighty":13.752998,"marketCap":65476795989},{"date":"2025-03-07","current":-82.972913,"twenty":-43.765472,"median":-23.273351,"eighty":13.720056,"marketCap":65431918130},{"date":"2025-03-14","current":-81.918752,"twenty":-44.36559,"median":-23.404228,"eighty":13.69943,"marketCap":64624116672},{"date":"2025-03-21","current":-77.113549,"twenty":-46.703645,"median":-23.571971,"eighty":13.681934,"marketCap":60809498674},{"date":"2025-03-28","current":-85.082441,"twenty":-50.561624,"median":-23.656456,"eighty":13.67268,"marketCap":66957765329},{"date":"2025-04-03","current":-139.968555,"twenty":-51.651807,"median":-23.75284,"eighty":13.662257,"marketCap":77100161418},{"date":"2025-04-11","current":-135.149196,"twenty":-52.531592,"median":-23.854164,"eighty":13.627238,"marketCap":73779199867},{"date":"2025-04-17","current":-136.201828,"twenty":-53.202931,"median":-23.974596,"eighty":13.597708,"marketCap":74452367749},{"date":"2025-04-25","current":-162.080631,"twenty":-54.264543,"median":-23.982021,"eighty":13.592632,"marketCap":88770184906},{"date":"2025-04-30","current":-140.988925,"twenty":-54.598286,"median":-23.982021,"eighty":13.592632,"marketCap":77415858930}],"updateTime":1746196839194}}}